您的位置: 首页 > 农业专利 > 详情页

LIQUID FORMULATION COMPRISING GM-CSF NEUTRALIZING COMPOUND
专利权人:
Amgen Research (Munich) GmbH;Takeda GmbH
发明人:
Thomas Urbig,Thomas Boehm,Wolfram Steinhilber,Michael Molhoj
申请号:
US15922777
公开号:
US20180207278A1
申请日:
2018.03.15
申请国别(地区):
US
年份:
2018
代理人:
摘要:
The present invention relates to aqueous formulations comprising a compound neutralizing GM-CSF in concentrations of at least about 20 mg/ml, a tonicity modifier and a buffer, wherein the composition is stable. The ingredients of the formulation preferably provide stability to the compound neutralizing GM-CSF in view of long-term storage. In a preferred aspect, the formulation is for use in therapy, preferably for use in the treatment of inflammatory and autoimmune disorders, preferably including allergic and psoriatic disorders, as well as arthritic and asthmatic disorders. Furthermore, a kit comprising the formulation of the invention is provided.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充